Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108595613 | 10859561 | 3 | F | 20140320 | 20160629 | 20150223 | 20160707 | PER | US-CELGENEUS-163-21880-14085761 | CELGENE | 60.88 | YR | M | Y | 105.78000 | KG | 20160707 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108595613 | 10859561 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | Y | U | A0314A | 21880 | 25 | MG | CAPSULES | QD | ||||
| 108595613 | 10859561 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | Y | U | A0314A | 21880 | 10 | MG | CAPSULES | |||||
| 108595613 | 10859561 | 3 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 20 MILLIGRAM | Y | U | A0314A | 21880 | 25 | MG | CAPSULES | ||||
| 108595613 | 10859561 | 4 | SS | MELPHALAN | MELPHALAN | 1 | Unknown | Y | U | 0 | 20 | MG | UNKNOWN | ||||||
| 108595613 | 10859561 | 5 | SS | MELPHALAN | MELPHALAN | 1 | Unknown | Y | U | 0 | UNKNOWN | ||||||||
| 108595613 | 10859561 | 6 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | Y | U | 66188 | 120 | MG | UNKNOWN | ||||||
| 108595613 | 10859561 | 7 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | Y | U | 66188 | UNKNOWN | ||||||||
| 108595613 | 10859561 | 8 | C | DECADRON | DEXAMETHASONE | 1 | Unknown | 0 | 20 | MG | UNKNOWN | /wk | |||||||
| 108595613 | 10859561 | 9 | C | NEUPOGEN | FILGRASTIM | 1 | Unknown | 0 | 480 | UG | UNKNOWN | QD | |||||||
| 108595613 | 10859561 | 10 | C | PLATELETS | HUMAN PLATELET, ALLOGENIC | 1 | Unknown | 480 MICROGRAM | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 108595613 | 10859561 | 1 | Plasma cell myeloma |
| 108595613 | 10859561 | 4 | Plasma cell myeloma |
| 108595613 | 10859561 | 6 | Plasma cell myeloma |
| 108595613 | 10859561 | 8 | Product used for unknown indication |
| 108595613 | 10859561 | 9 | Product used for unknown indication |
| 108595613 | 10859561 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 108595613 | 10859561 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 108595613 | 10859561 | Neutropenia | |
| 108595613 | 10859561 | Pancytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 108595613 | 10859561 | 1 | 20140130 | 0 | ||
| 108595613 | 10859561 | 2 | 20140227 | 20140320 | 0 | |
| 108595613 | 10859561 | 4 | 20140130 | 0 | ||
| 108595613 | 10859561 | 5 | 20140227 | 20140320 | 0 | |
| 108595613 | 10859561 | 6 | 20140130 | 0 | ||
| 108595613 | 10859561 | 7 | 20140227 | 20140320 | 0 | |
| 108595613 | 10859561 | 9 | 20140320 | 20140402 | 0 |